Sabra Health Care REIT, Inc.
NASDAQ:SBRAREIT - Healthcare Facilities
-$0.11 today
- Market cap
- $5.40B
- Beta
- 0.63
- P/E (TTM)
- 29.0
- EPS (TTM)
- $0.62
- Dividend yield
- 6.69%
Volume 2.42M
Average 2.46M
SBRA Interest Expense
Cost of servicing the company's debt during the period.
Sabra Health Care REIT, Inc.NASDAQ: SBRA
Interest Expense · Q2 FY2026 · quarter ended Jun 2026
Interest expense growth accelerates
Q2 FY2026 interest expense of $29.78M rose 8.1% year over year, ahead of the +5.3% change in trailing-twelve-month interest expense. Sequentially, it rose 4.8% from the prior quarter. Over 3 fiscal years it compounded at +2.2% a year.
Context
- Interest expense amounted to 14.5% of revenue in FY2025, down 1.9 pp from a year earlier.
- Interest expense increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +8.1% holds above the trailing-twelve-month pace of +5.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 112.49M USD
- Year-over-year change
- -2.4%
- 4-year CAGR
- +3.3%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 112.49M | -2.4% |
| FY2024 | 2024-12-31 | 115.27M | +2.0% |
| FY2023 | 2023-12-31 | 112.96M | +7.1% |
| FY2022 | 2022-12-31 | 105.47M | +6.9% |
| FY2021 | 2021-12-31 | 98.63M | — |
Interest Expense vs competitors
How SBRA compares with its peers on the latest reported figures
- SBRA's LTM Jun 2026 interest expense of $118.16M is the 5th highest of the 11 companies compared; the peer median is $68.21M.
- Its year-over-year change of +5.3% is the 6th highest of 9, against a peer median of +22.3%.
- Interest expense amounts to 13.7% of revenue for SBRA, versus a peer median of 13.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $771.07M | +27.9% | +7.2% | 5.6% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $646.56M | +372.5% | +11.5% | 63.4% |
| LTM Sep 2026 | $344.11M | +16.6% | +20.8% | 15.3% | |
| LTM Jun 2026 | $207.83M | -3.4% | -1.9% | 16.1% | |
| LTM Jun 2026 | $118.16M | +5.3% | +2.2% | 13.7% | |
| LTM Sep 2026 | $75M | -22.1% | -6.8% | 2.8% | |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $61.42M | -9.1% | +5.8% | 18.0% |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | $61.3M | — | +5.8% | 17.9% |
| LTM Sep 2026 | $56.73M | +33.7% | +10.6% | 12.4% | |
| LTM Sep 2026 | $55.66M | +48.6% | +13.4% | 9.0% | |
| FY2025 | $1.64M | — | — | 0.2% | |
| Peer median (excluding SBRA) | $68.21M | +22.3% | +7.2% | 13.9% | |
Competitors are the stored peer set for SBRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 569.55M | 624.81M | 647.51M | 703.24M | 774.63M |
| Cost of Revenue | 141.2M | 162.61M | 195.25M | 227.09M | 271.11M |
| Gross Profit | 428.34M | 462.2M | 452.27M | 476.15M | 503.53M |
| Gross Margin | 75.2% | 74.0% | 69.8% | 67.7% | 65.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 34.67M | 39.57M | 47.47M | 50.07M | 53.71M |
| Operating Expenses | 217.6M | 227.36M | 230.56M | 219.12M | 239.66M |
| Depreciation & Amortization | 178.99M | 187.78M | 183.09M | 169.62M | 187M |
| EBITDA | 166.21M | 216.89M | 311.81M | 412.61M | 456.83M |
| EBITDA Margin | 29.2% | 34.7% | 48.2% | 58.7% | 59.0% |
| Operating Income | 210.75M | 234.84M | 221.71M | 257.03M | 263.87M |
| Operating Margin | 37.0% | 37.6% | 34.2% | 36.5% | 34.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 98.63M | 105.47M | 112.96M | 115.27M | 112.49M |
| Other Income / Expenses | (322.16M) | (311.21M) | (205.95M) | (129.31M) | (106.52M) |
| Income Before Tax | (111.41M) | (76.36M) | 15.76M | 127.72M | 157.35M |
| Pre-Tax Margin | -19.6% | -12.2% | 2.4% | 18.2% | 20.3% |
| Income Tax Expense | 1.85M | 1.24M | 2M | 1.01M | 1.84M |
| Net Income | (113.26M) | (77.61M) | 13.76M | 126.71M | 155.61M |
| Net Margin | -19.9% | -12.4% | 2.1% | 18.0% | 20.1% |
| EPS (Basic) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| EPS (Diluted) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| Weighted Avg Shares | 219.07M | 230.95M | 231.2M | 233.5M | 241.31M |
| Weighted Avg Shares (Diluted) | 219.07M | 230.95M | 232.79M | 236.05M | 244.5M |
Sabra Health Care REIT, Inc.
NASDAQ:SBRA
Intrinsic Alpha fair value
Locked
Current Price
$20.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.